The AID Dilemma. Infection, or Cancer?

Advances in Cancer Research

Volumn 113, Issue , 2012, Pages 1-44

  Honjo, Tasuku ^a   Kobayashi, Maki ^a   Begum, Nasim ^a   Kotani, Ai ^b   Sabouri, Somayeh ^a   Nagaoka, Hitoshi ^c  

^a KYOTO UNIVERSITY   (Japan)

^b TOKAI UNIVERSITY   (Japan)

^c GIFU UNIVERSITY   (Japan)

Author keywords

Class switch recombination; Genome instability; H3K4me3; Non B form; Somatic hypermutation; Target specificity; Topoisomerase 1; Transcription; Triplet diseases

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 1; CENTROMERE PROTEIN A; CYCLIC AMP DEPENDENT PROTEIN KINASE; DNA; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; DNA TOPOISOMERASE; EXODEOXYRIBONUCLEASE III; HISTONE H3; IMMUNOGLOBULIN; MESSENGER RNA; MISMATCH REPAIR PROTEIN; PROTEIN MDM2; RNA POLYMERASE II; URACIL DNA GLYCOSIDASE;

AMINO TERMINAL SEQUENCE; ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CD4+ T LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; CLASSICAL HODGKIN LYMPHOMA; DEAMINATION; DNA CLEAVAGE; DNA MODIFICATION; ENZYME REGULATION; EPSTEIN BARR VIRUS; FOLLICULAR LYMPHOMA; GENE REARRANGEMENT; GENE TARGETING; GENETIC RECOMBINATION; GENOMIC INSTABILITY; HELICOBACTER PYLORI; HEPATITIS C VIRUS; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOGLOBULIN GENE; INFECTION; INFECTION PREVENTION; LARGE CELL LYMPHOMA; LIVER CELL CARCINOMA; MEIOSIS; MISMATCH REPAIR; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NASOPHARYNX CARCINOMA; NEOPLASM; NONHUMAN; PAPILLOMA VIRUS; PHENOTYPE; PLASMACYTOMA; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RNA EDITING; SOMATIC HYPERMUTATION; STOMACH CANCER; T CELL LEUKEMIA; T CELL LYMPHOMA; UTERINE CERVIX CANCER; VDJ RECOMBINATION;

EID: 84858395631     PISSN: 0065230X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-394280-7.00001-4     Document Type: Chapter

References (201)

1. Aguilera A. The connection between transcription and genomic instability. EMBO J. 2002, 21:195-201.
2. Albesiano E., Messmer B.T., Damle R.N., Allen S.L., Rai K.R., Chiorazzi N. Activation-induced cytidine deaminase in chronic lymphocytic leukemia B cells: expression as multiple forms in a dynamic, variably sized fraction of the clone. Blood 2003, 102:3333-3339.
3. Alizadeh A.A., Eisen M.B., Davis R.E., Ma C., Lossos I.S., Rosenwald A., Boldrick J.C., Sabet H., Tran T., Yu X., Powell J.I., Yang L., et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000, 403:503-511.
4. Babbage G., Garand R., Robillard N., Zojer N., Stevenson F.K., Sahota S.S. Mantle cell lymphoma with t(11;14) and unmutated or mutated VH genes expresses AID and undergoes isotype switch events. Blood 2004, 103:2795-2798.
5. Babbage G., Ottensmeier C.H., Blaydes J., Stevenson F.K., Sahota S.S. Immunoglobulin heavy chain locus events and expression of activation-induced cytidine deaminase in epithelial breast cancer cell lines. Cancer Res. 2006, 66:3996-4000.
6. Bacolla A., Wojciechowska M., Kosmider B., Larson J.E., Wells R.D. The involvement of non-B DNA structures in gross chromosomal rearrangements. DNA Repair (Amst.) 2006, 5:1161-1170.
7. Barreto V., Reina-San-Martin B., Ramiro A.R., McBride K.M., Nussenzweig M.C. C-terminal deletion of AID uncouples class switch recombination from somatic hypermutation and gene conversion. Mol. Cell 2003, 12:501-508.
8. Bassing C.H., Swat W., Alt F.W. The mechanism and regulation of chromosomal V(D)J recombination. Cell 2002, 109(Suppl.):S45-S55.
9. Basu U., Chaudhuri J., Alpert C., Dutt S., Ranganath S., Li G., Schrum J.P., Manis J.P., Alt F.W. The AID antibody diversification enzyme is regulated by protein kinase A phosphorylation. Nature 2005, 438:508-511.
10. Baudat F., Buard J., Grey C., Fledel-Alon A., Ober C., Przeworski M., Coop G., de Massy B. PRDM9 is a major determinant of meiotic recombination hotspots in humans and mice. Science 2010, 327:836-840.
11. Begum N.A., Kinoshita K., Kakazu N., Muramatsu M., Nagaoka H., Shinkura R., Biniszkiewicz D., Boyer L.A., Jaenisch R., Honjo T. Uracil DNA glycosylase activity is dispensable for immunoglobulin class switch. Science 2004, 305:1160-1163.
12. Begum N.A., Izumi N., Nishikori M., Nagaoka H., Shinkura R., Honjo T. Requirement of non-canonical activity of uracil DNA glycosylase for class switch recombination. J. Biol. Chem. 2007, 282:731-742.
13. Begum N.A., Stanlie A., Doi T., Sasaki Y., Jin H.W., Kim Y.S., Nagaoka H., Honjo T. Further evidence for involvement of a noncanonical function of uracil DNA glycosylase in class switch recombination. Proc. Natl. Acad. Sci. U S A 2009, 106:2752-2757.
14. Betz A.G., Milstein C., Gonzalez-Fernandez A., Pannell R., Larson T., Neuberger M.S. Elements regulating somatic hypermutation of an immunoglobulin kappa gene: critical role for the intron enhancer/matrix attachment region. Cell 1994, 77:239-248.
15. Braeuninger A., Kuppers R., Strickler J.G., Wacker H.H., Rajewsky K., Hansmann M.L. Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells. Proc. Natl. Acad. Sci. USA 1997, 94:9337-9342.
16. Bransteitter R., Pham P., Scharff M.D., Goodman M.F. Activation-induced cytidine deaminase deaminates deoxycytidine on single-stranded DNA but requires the action of RNase. Proc. Natl. Acad. Sci. USA 2003, 100:4102-4107.
17. Burkovics P., Szukacsov V., Unk I., Haracska L. Human Ape2 protein has a 3'-5' exonuclease activity that acts preferentially on mismatched base pairs. Nucleic Acids Res. 2006, 34:2508-2515.
18. Cerutti A., Zan H., Kim E.C., Shah S., Schattner E.J., Schaffer A., Casali P. Ongoing in vivo immunoglobulin class switch DNA recombination in chronic lymphocytic leukemia B cells. J. Immunol. 2002, 169:6594-6603.
19. Chaudhuri J., Tian M., Khuong C., Chua K., Pinaud E., Alt F.W. Transcription-targeted DNA deamination by the AID antibody diversification enzyme. Nature 2003, 422:726-730.
20. Chaudhuri J., Khuong C., Alt F.W. Replication protein A interacts with AID to promote deamination of somatic hypermutation targets. Nature 2004, 430:992-998.
21. Conticello S.G., Ganesh K., Xue K., Lu M., Rada C., Neuberger M.S. Interaction between antibody-diversification enzyme AID and spliceosome-associated factor CTNNBL1. Mol. Cell 2008, 31:474-484.
22. Cory S., Jackson J., Adams J.M. Deletions in the constant region locus can account for switches in immunoglobulin heavy chain expression. Nature 1980, 285:450-456.
23. Crouch E.E., Li Z., Takizawa M., Fichtner-Feigl S., Gourzi P., Montano C., Feigenbaum L., Wilson P., Janz S., Papavasiliou F.N., Casellas R. Regulation of AID expression in the immune response. J. Exp. Med. 2007, 204:1145-1156.
24. Damle R.N., Wasil T., Fais F., Ghiotto F., Valetto A., Allen S.L., Buchbinder A., Budman D., Dittmar K., Kolitz J., Lichtman S.M., Schulman P., et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999, 94:1840-1847.
25. Davis I.J., Hsi B.L., Arroyo J.D., Vargas S.O., Yeh Y.A., Motyckova G., Valencia P., Perez-Atayde A.R., Argani P., Ladanyi M., Fletcher J.A., Fisher D.E. Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation. Proc. Natl. Acad. Sci. USA 2003, 100:6051-6056.
26. de Sanjose S., Benavente Y., Vajdic C.M., Engels E.A., Morton L.M., Bracci P.M., Spinelli J.J., Zheng T., Zhang Y., Franceschi S., Talamini R., Holly E.A., et al. Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clin. Gastroenterol. Hepatol. 2008, 6:451-458.
27. De Silva F.S., Moss B. Vaccinia virus uracil DNA glycosylase has an essential role in DNA synthesis that is independent of its glycosylase activity: catalytic site mutations reduce virulence but not virus replication in cultured cells. J. Virol. 2003, 77:159-166.
28. De Silva F.S., Moss B. Effects of vaccinia virus uracil DNA glycosylase catalytic site and deoxyuridine triphosphatase deletion mutations individually and together on replication in active and quiescent cells and pathogenesis in mice. Virol. J. 2008, 5:145.
29. Di Noia J., Neuberger M.S. Altering the pathway of immunoglobulin hypermutation by inhibiting uracil-DNA glycosylase. Nature 2002, 419:43-48.
30. Di Noia J.M., Rada C., Neuberger M.S. SMUG1 is able to excise uracil from immunoglobulin genes: insight into mutation versus repair. Embo J. 2006, 25:585-595.
31. Dijkman R., Tensen C.P., Buettner M., Niedobitek G., Willemze R., Vermeer M.H. Primary cutaneous follicle center lymphoma and primary cutaneous large B-cell lymphoma, leg type, are both targeted by aberrant somatic hypermutation but demonstrate differential expression of AID. Blood 2006, 107:4926-4929.
32. Doi T., Kinoshita K., Ikegawa M., Muramatsu M., Honjo T. De novo protein synthesis is required for the activation-induced cytidine deaminase function in class-switch recombination. Proc. Natl. Acad. Sci. USA 2003, 100:2634-2638.
33. Doi T., Kato L., Ito S., Shinkura R., Wei M., Nagaoka H., Wang J., Honjo T. The C-terminal region of activation-induced cytidine deaminase is responsible for a recombination function other than DNA cleavage in class switch recombination. Proc. Natl. Acad. Sci. USA 2009, 106:2758-2763.
34. Dorsett Y., McBride K.M., Jankovic M., Gazumyan A., Thai T.H., Robbiani D.F., Di Virgilio M., Reina San-Martin B., Heidkamp G., Schwickert T.A., Eisenreich T., Rajewsky K., et al. MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation. Immunity 2008, 28:630-638.
35. Dunnick W., Rabbitts T.H., Milstein C. An immunoglobulin deletion mutant with implications for the heavy-chain switch and RNA splicing. Nature 1980, 286:669-675.
36. Dunnick W., Hertz G.Z., Scappino L., Gritzmacher C. DNA sequences at immunoglobulin switch region recombination sites. Nucleic Acids Res. 1993, 21:365-372.
37. Durandy A., Peron S., Taubenheim N., Fischer A. Activation-induced cytidine deaminase: structure-function relationship as based on the study of mutants. Hum. Mutat. 2006, 27:1185-1191.
38. Ellyard J.I., Benk A.S., Taylor B., Rada C., Neuberger M.S. The dependence of Ig class-switching on the nuclear export sequence of AID likely reflects interaction with factors additional to Crm1 exportin. Eur. J. Immunol. 2011, 41:485-490.
39. Endo Y., Marusawa H., Kinoshita K., Morisawa T., Sakurai T., Okazaki I.M., Watashi K., Shimotohno K., Honjo T., Chiba T. Expression of activation-induced cytidine deaminase in human hepatocytes via NF-kappaB signaling. Oncogene 2007, 26:5587-5595.
40. Endo Y., Marusawa H., Kou T., Nakase H., Fujii S., Fujimori T., Kinoshita K., Honjo T., Chiba T. Activation-induced cytidine deaminase links between inflammation and the development of colitis-associated colorectal cancers. Gastroenterology 2008, 135:889-898. 898, e881-883.
41. Epeldegui M., Hung Y.P., McQuay A., Ambinder R.F., Martinez-Maza O. Infection of human B cells with Epstein-Barr virus results in the expression of somatic hypermutation-inducing molecules and in the accrual of oncogene mutations. Mol. Immunol. 2007, 44:934-942.
42. Fagarasan S., Muramatsu M., Suzuki K., Nagaoka H., Hiai H., Honjo T. Critical roles of activation-induced cytidine deaminase in the homeostasis of gut flora. Science 2002, 298:1424-1427.
43. Faili A., Aoufouchi S., Gueranger Q., Zober C., Leon A., Bertocci B., Weill J.C., Reynaud C.A. AID-dependent somatic hypermutation occurs as a DNA single-strand event in the BL2 cell line. Nat. Immunol. 2002, 3:815-821.
44. Feldhahn N., Henke N., Melchior K., Duy C., Soh B.N., Klein F., von Levetzow G., Giebel B., Li A., Hofmann W.K., Jumaa H., Muschen M. Activation-induced cytidine deaminase acts as a mutator in BCR-ABL1-transformed acute lymphoblastic leukemia cells. J. Exp. Med. 2007, 204:1157-1166.
45. Forconi F., Sahota S.S., Raspadori D., Ippoliti M., Babbage G., Lauria F., Stevenson F.K. Hairy cell leukemia: at the crossroad of somatic mutation and isotype switch. Blood 2004, 104:3312-3317.
46. Fugmann S.D., Villey I.J., Ptaszek L.M., Schatz D.G. Identification of two catalytic residues in RAG1 that define a single active site within the RAG1/RAG2 protein complex. Mol. Cell 2000, 5:97-107.
47. Gazumyan A., Timachova K., Yuen G., Siden E., Di Virgilio M., Woo E.M., Chait B.T., San-Martin B.R., Nussenzweig M.C., McBride K.M. Amino terminal phosphorylation of activation-induced cytidine deaminase suppresses c-myc-IgH translocation. Mol. Cell. Biol. 2010, 31:442-449.
48. Gellert M. V(D)J recombination: RAG proteins, repair factors, and regulation. Annu. Rev. Biochem. 2002, 71:101-132.
49. Gordon M.S., Kanegai C.M., Doerr J.R., Wall R. Somatic hypermutation of the B cell receptor genes B29 (Igbeta, CD79b) and mb1 (Igalpha, CD79a). Proc. Natl. Acad. Sci. USA 2003, 100:4126-4131.
50. Greeve J., Philipsen A., Krause K., Klapper W., Heidorn K., Castle B.E., Janda J., Marcu K.B., Parwaresch R. Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas. Blood 2003, 101:3574-3580.
51. Greiner A., Tobollik S., Buettner M., Jungnickel B., Herrmann K., Kremmer E., Niedobitek G. Differential expression of activation-induced cytidine deaminase (AID) in nodular lymphocyte-predominant and classical Hodgkin lymphoma. J. Pathol. 2005, 205:541-547.
52. Gruber T.A., Chang M.S., Sposto R., Muschen M. Activation-induced cytidine deaminase accelerates clonal evolution in BCR-ABL1-driven B-cell lineage acute lymphoblastic leukemia. Cancer Res. 2010, 70:7411-7420.
53. Guenzel C.A., Herate C., Le Rouzic E., Maidou-Peindara P., Sadler H.A., Rouyez M.C., Mansky L.M., Benichou S. Recruitment of the nuclear form of uracil DNA glycosylase into virus particles participates in the full infectivity of HIV-1. J. virol. 2011.
54. Guikema J.E., Linehan E.K., Tsuchimoto D., Nakabeppu Y., Strauss P.R., Stavnezer J., Schrader C.E. APE1- and APE2-dependent DNA breaks in immunoglobulin class switch recombination. J. Exp. Med. 2007, 204:3017-3026.
55. Hamblin T. Chronic lymphocytic leukaemia: one disease or two?. Ann. Hematol. 2002, 81:299-303.
56. Han L., Masani S., Yu K. Cutting edge: CTNNBL1 is dispensable for Ig class switch recombination. J. Immunol. 2010, 185:1379-1381.
57. Hardianti M.S., Tatsumi E., Syampurnawati M., Furuta K., Saigo K., Kawano S., Kumagai S., Nakamura F., Matsuo Y. Expression of activation-induced cytidine deaminase (AID) in Burkitt lymphoma cells: rare AID-negative cell lines with the unmutated rearranged VH gene. Leuk. Lymphoma 2004, 45:155-160.
58. Hardianti M.S., Tatsumi E., Syampurnawati M., Furuta K., Saigo K., Nakamachi Y., Kumagai S., Ohno H., Tanabe S., Uchida M., Yasuda N. Activation-induced cytidine deaminase expression in follicular lymphoma: association between AID expression and ongoing mutation in FL. Leukemia 2004, 18:826-831.
59. Harris R.S., Petersen-Mahrt S.K., Neuberger M.S. RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. Mol. Cell 2002, 10:1247-1253.
60. Hartsuiker E., Mizuno K., Molnar M., Kohli J., Ohta K., Carr A. Ctp1CtIP and Rad32Mre11 nuclease activity are required for Rec12Spo11 removal, but Rec12Spo11 removal is dispensable for other MRN-dependent meiotic functions. Mol. Cell. Biol. 2009, 29:1671-1681.
61. Heintel D., Kroemer E., Kienle D., Schwarzinger I., Gleiss A., Schwarzmeier J., Marculescu R., Le T., Mannhalter C., Gaiger A., Stilgenbauer S., Dohner H., et al. High expression of activation-induced cytidine deaminase (AID) mRNA is associated with unmutated IGVH gene status and unfavourable cytogenetic aberrations in patients with chronic lymphocytic leukaemia. Leukemia 2004, 18:756-762.
62. Hobeika E., Thiemann S., Storch B., Jumaa H., Nielsen P.J., Pelanda R., Reth M. Testing gene function early in the B cell lineage in mb1-cre mice. Proc. Natl. Acad. Sci. USA 2006, 103:13789-13794.
63. Hoefnagel J.J., Dijkman R., Basso K., Jansen P.M., Hallermann C., Willemze R., Tensen C.P., Vermeer M.H. Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling. Blood 2005, 105:3671-3678.
64. Honjo T., Kataoka T. Organization of immunoglobulin heavy chain genes and allelic deletion model. Proc. Natl. Acad. Sci. USA 1978, 75:2140-2144.
65. Honjo T., Kinoshita K., Muramatsu M. Molecular mechanism of class switch recombination: linkage with somatic hypermutation. Annu. Rev. Immunol. 2002, 20:165-196.
66. Honjo T., Nagaoka H., Shinkura R., Muramatsu M. AID to overcome the limitations of genomic information. Nat. Immunol. 2005, 6:655-661.
67. Hubert L., Lin Y., Dion V., Wilson J.H. Topoisomerase 1 and single-strand break repair modulate transcription-induced CAG repeat contraction in human cells. Mol. Cell. Biol. 2011, 31:3105-3112.
68. Iacobucci I., Lonetti A., Messa F., Ferrari A., Cilloni D., Soverini S., Paoloni F., Arruga F., Ottaviani E., Chiaretti S., Messina M., Vignetti M., et al. Different isoforms of the B-cell mutator activation-induced cytidine deaminase are aberrantly expressed in BCR-ABL1-positive acute lymphoblastic leukemia patients. Leukemia 2010, 24:66-73.
69. Ide Y., Tsuchimoto D., Tominaga Y., Nakashima M., Watanabe T., Sakumi K., Ohno M., Nakabeppu Y. Growth retardation and dyslymphopoiesis accompanied by G2/M arrest in APEX2-null mice. Blood 2004, 104:4097-4103.
70. Imai K., Slupphaug G., Lee W.I., Revy P., Nonoyama S., Catalan N., Yel L., Forveille M., Kavli B., Krokan H.E., Ochs H.D., Fischer A., Durandy A. Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination. Nat. Immunol. 2003, 4:1023-1028.
71. Imai K., Zhu Y., Revy P., Morio T., Mizutani S., Fischer A., Nonoyama S., Durandy A. Analysis of class switch recombination and somatic hypermutation in patients affected with autosomal dominant hyper-IgM syndrome type 2. Clin. Immunol. 2005, 115:277-285.
72. Ise W., Kohyama M., Schraml B.U., Zhang T., Schwer B., Basu U., Alt F.W., Tang J., Oltz E.M., Murphy T.L., Murphy K.M. The transcription factor BATF controls the global regulators of class-switch recombination in both B cells and T cells. Nat. Immunol. 2011, 12:536-543.
73. Ishikawa C., Nakachi S., Senba M., Sugai M., Mori N. Activation of AID by human T-cell leukemia virus Tax oncoprotein and the possible role of its constitutive expression in ATL genesis. Carcinogenesis 2011, 32:110-119.
74. Ito S., Nagaoka H., Shinkura R., Begum N., Muramatsu M., Nakata M., Honjo T. Activation-induced cytidine deaminase shuttles between nucleus and cytoplasm like apolipoprotein B mRNA editing catalytic polypeptide 1. Proc. Natl. Acad. Sci. USA 2004, 101:1975-1980.
75. Jeevan-Raj B.P., Robert I., Heyer V., Page A., Wang J.H., Cammas F., Alt F.W., Losson R., Reina-San-Martin B. Epigenetic tethering of AID to the donor switch region during immunoglobulin class switch recombination. J. Exp. Med. 2011, 208:1649-1660.
76. Jung S., Rajewsky K., Radbruch A. Shutdown of class switch recombination by deletion of a switch region control element. Science 1993, 259:984-987.
77. Kanzler H., Kuppers R., Hansmann M.L., Rajewsky K. Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J. Exp. Med. 1996, 184:1495-1505.
78. Kapitonov V.V., Jurka J. RAG1 core and V(D)J recombination signal sequences were derived from Transib transposons. PLoS Biol. 2005, 3:e181.
79. Kato L., Begum N.A., Burroughs A.M., Doi T., Kawai J., Daub C.O., Kawaguchi T., Matsuda F., Hayashizaki Y., Honjo T. Nonimmunoglobulin target loci of activation-induced cytidine deaminase (AID) share unique features with immunoglobulin genes. Proc. Natl. Acad. Sci. USA 2012, In Press.
80. Kavli B., Andersen S., Otterlei M., Liabakk N.B., Imai K., Fischer A., Durandy A., Krokan H.E., Slupphaug G. B cells from hyper-IgM patients carrying UNG mutations lack ability to remove uracil from ssDNA and have elevated genomic uracil. J. Exp. Med. 2005, 201:2011-2021.
81. Kim C.J., Song J.H., Cho Y.G., Cao Z., Kim S.Y., Nam S.W., Lee J.Y., Park W.S. Activation-induced cytidine deaminase expression in gastric cancer. Tumour Biol. 2007, 28:333-339.
82. Klapper W., Szczepanowski M., Heidorn K., Muschen M., Liedtke S., Sotnikova A., Andersen N.S., Greeve J., Parwaresch R. Immunoglobulin class-switch recombination occurs in mantle cell lymphomas. J. Pathol. 2006, 209:250-257.
83. Klein U., Tu Y., Stolovitzky G.A., Mattioli M., Cattoretti G., Husson H., Freedman A., Inghirami G., Cro L., Baldini L., Neri A., Califano A., et al. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J. Exp. Med. 2001, 194:1625-1638.
84. Klemm L., Duy C., Iacobucci I., Kuchen S., von Levetzow G., Feldhahn N., Henke N., Li Z., Hoffmann T.K., Kim Y.M., Hofmann W.K., Jumaa H., et al. The B cell mutator AID promotes B lymphoid blast crisis and drug resistance in chronic myeloid leukemia. Cancer Cell 2009, 16:232-245.
85. Kobayashi M., Aida M., Nagaoka H., Begum N.A., Kitawaki Y., Nakata M., Stanlie A., Doi T., Kato L., Okazaki I.M., Shinkura R., Muramatsu M., et al. AID-induced decrease in topoisomerase 1 induces DNA structural alteration and DNA cleavage for class switch recombination. Proc. Natl. Acad. Sci. USA 2009, 106:22375-22380.
86. Kobayashi M., Sabouri Z., Sabouri S., Kitawaki Y., Pommier Y., Abe T., Kiyonari H., Honjo T. Decrease in topoisomerase I is responsible for AID-dependent somatic hypermutation. Proc. Natl. Acad. Sci. USA 2011, 108:19305-19310.
87. Kolar G.R., Mehta D., Pelayo R., Capra J.D. A novel human B cell subpopulation representing the initial germinal center population to express AID. Blood 2007, 109:2545-2552.
88. Komori J., Marusawa H., Machimoto T., Endo Y., Kinoshita K., Kou T., Haga H., Ikai I., Uemoto S., Chiba T. Activation-induced cytidine deaminase links bile duct inflammation to human cholangiocarcinoma. Hepatology 2008, 47:888-896.
89. Kotani A., Okazaki I.M., Muramatsu M., Kinoshita K., Begum N.A., Nakajima T., Saito H., Honjo T. A target selection of somatic hypermutations is regulated similarly between T and B cells upon activation-induced cytidine deaminase expression. Proc. Natl. Acad. Sci. USA 2005, 102:4506-4511.
90. Kotani A., Kakazu N., Tsuruyama T., Okazaki I.M., Muramatsu M., Kinoshita K., Nagaoka H., Yabe D., Honjo T. Activation-induced cytidine deaminase (AID) promotes B cell lymphomagenesis in Emu-cmyc transgenic mice. Proc. Natl. Acad. Sci. USA 2007, 104:1616-1620.
91. Kou T., Marusawa H., Kinoshita K., Endo Y., Okazaki I.M., Ueda Y., Kodama Y., Haga H., Ikai I., Chiba T. Expression of activation-induced cytidine deaminase in human hepatocytes during hepatocarcinogenesis. Int. J. Cancer 2007, 120:469-476.
92. Kovalchuk A.L., duBois W., Mushinski E., McNeil N.E., Hirt C., Qi C.F., Li Z., Janz S., Honjo T., Muramatsu M., Ried T., Behrens T., et al. AID-deficient Bcl-xL transgenic mice develop delayed atypical plasma cell tumors with unusual Ig/Myc chromosomal rearrangements. J. Exp. Med. 2007, 204:2989-3001.
93. Kracker S., Imai K., Gardes P., Ochs H.D., Fischer A., Durandy A.H. Impaired induction of DNA lesions during immunoglobulin class-switch recombination in humans influences end-joining repair. Proc. Natl. Acad. Sci. USA 2010, 107:22225-22230.
94. Kuppers R., Dalla-Favera R. Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene 2001, 20:5580-5594.
95. Kuppers R., Schwering I., Brauninger A., Rajewsky K., Hansmann M.L. Biology of Hodgkin's lymphoma. Ann. Oncol. 2002, 13(Suppl. 1):11-18.
96. Kwon K., Hutter C., Sun Q., Bilic I., Cobaleda C., Malin S., Busslinger M. Instructive role of the transcription factor E2A in early B lymphopoiesis and germinal center B cell development. Immunity 2008, 28:751-762.
97. Lee-Theilen M., Matthews A.J., Kelly D., Zheng S., Chaudhuri J. CtIP promotes microhomology-mediated alternative end joining during class-switch recombination. Nat. Struct. Mol. Biol. 2011, 18:75-79.
98. Levin J.Z., Berger M.F., Adiconis X., Rogov P., Melnikov A., Fennell T., Nusbaum C., Garraway L.A., Gnirke A. Targeted next-generation sequencing of a cancer transcriptome enhances detection of sequence variants and novel fusion transcripts. Genome Biol. 2009, 10:R115.
99. Lippert M.J., Kim N., Cho J.E., Larson R.P., Schoenly N.E., O'Shea S.H., Jinks-Robertson S. Role for topoisomerase 1 in transcription-associated mutagenesis in yeast. Proc. Natl. Acad. Sci. USA 2011, 108:698-703.
100. Liu Y., Subrahmanyam R., Chakraborty T., Sen R., Desiderio S. A plant homeodomain in RAG-2 that binds hypermethylated lysine 4 of histone H3 is necessary for efficient antigen-receptor-gene rearrangement. Immunity 2007, 27:561-571.
101. Liu M., Duke J.L., Richter D.J., Vinuesa C.G., Goodnow C.C., Kleinstein S.H., Schatz D.G. Two levels of protection for the B cell genome during somatic hypermutation. Nature 2008, 451:841-845.
102. Lossos I.S., Levy R., Alizadeh A.A. AID is expressed in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas and is not correlated with intraclonal heterogeneity. Leukemia 2004, 18:1775-1779.
103. MacDuff D.A., Neuberger M.S., Harris R.S. MDM2 can interact with the C-terminus of AID but it is inessential for antibody diversification in DT40 B cells. Mol. Immunol. 2006, 43:1099-1108.
104. Machida K., Cheng K.T., Sung V.M., Shimodaira S., Lindsay K.L., Levine A.M., Lai M.Y., Lai M.M. Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes. Proc. Natl. Acad. Sci. USA 2004, 101:4262-4267.
105. Mai T., Zan H., Zhang J., Hawkins J.S., Xu Z., Casali P. Estrogen receptors bind to and activate the HOXC4/HoxC4 promoter to potentiate HoxC4-mediated activation-induced cytosine deaminase induction, immunoglobulin class switch DNA recombination, and somatic hypermutation. J. Biol. Chem. 2010, 285:37797-37810.
106. Maki R., Traunecker A., Sakano H., Roeder W., Tonegawa S. Exon shuffling generates an immunoglobulin heavy chain gene. Proc. Natl. Acad. Sci. USA 1980, 77:2138-2142.
107. Marafioti T., Hummel M., Foss H.D., Laumen H., Korbjuhn P., Anagnostopoulos I., Lammert H., Demel G., Theil J., Wirth T., Stein H. Hodgkin and Reed-Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. Blood 2000, 95:1443-1450.
108. Marantidou F., Dagklis A., Stalika E., Korkolopoulou P., Saetta A., Anagnostopoulos A., Laoutaris N., Stamatopoulos K., Belessi C., Scouras Z., Patsouris E. Activation-induced cytidine deaminase splicing patterns in chronic lymphocytic leukemia. Blood Cells Mol. Dis. 2010, 44:262-267.
109. Matsumoto Y., Marusawa H., Kinoshita K., Endo Y., Kou T., Morisawa T., Azuma T., Okazaki I.M., Honjo T., Chiba T. Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat. Med. 2007, 13:470-476.
110. Matthews A.G., Kuo A.J., Ramon-Maiques S., Han S., Champagne K.S., Ivanov D., Gallardo M., Carney D., Cheung P., Ciccone D.N., Walter K.L., Utz P.J., et al. RAG2 PHD finger couples histone H3 lysine 4 trimethylation with V(D)J recombination. Nature 2007, 450:1106-1110.
111. Maul R.W., Saribasak H., Martomo S.A., McClure R.L., Yang W., Vaisman A., Gramlich H.S., Schatz D.G., Woodgate R., Wilson D.M., Gearhart P.J. Uracil residues dependent on the deaminase AID in immunoglobulin gene variable and switch regions. Nat. Immunol. 2011, 12:70-76.
112. McBride K.M., Gazumyan A., Woo E.M., Barreto V.M., Robbiani D.F., Chait B.T., Nussenzweig M.C. Regulation of hypermutation by activation-induced cytidine deaminase phosphorylation. Proc. Natl. Acad. Sci. USA 2006, 103:8798-8803.
113. McBride K.M., Gazumyan A., Woo E.M., Schwickert T.A., Chait B.T., Nussenzweig M.C. Regulation of class switch recombination and somatic mutation by AID phosphorylation. J. Exp. Med 2008, 205:2585-2594.
114. McCarthy H., Wierda W.G., Barron L.L., Cromwell C.C., Wang J., Coombes K.R., Rangel R., Elenitoba-Johnson K.S., Keating M.J., Abruzzo L.V. High expression of activation-induced cytidine deaminase (AID) and splice variants is a distinctive feature of poor-prognosis chronic lymphocytic leukemia. Blood 2003, 101:4903-4908.
115. Miao Z.H., Player A., Shankavaram U., Wang Y.H., Zimonjic D.B., Lorenzi P.L., Liao Z.Y., Liu H., Shimura T., Zhang H.L., Meng L.H., Zhang Y.W., et al. Nonclassic functions of human topoisomerase I: genome-wide and pharmacologic analyses. Cancer Res. 2007, 67:8752-8761.
116. Migliazza A., Martinotti S., Chen W., Fusco C., Ye B.H., Knowles D.M., Offit K., Chaganti R.S., Dalla-Favera R. Frequent somatic hypermutation of the 5' noncoding region of the BCL6 gene in B-cell lymphoma. Proc. Natl. Acad. Sci. USA 1995, 92:12520-12524.
117. Min I.M., Schrader C.E., Vardo J., Luby T.M., D'Avirro N., Stavnezer J., Selsing E. The Smu tandem repeat region is critical for Ig isotype switching in the absence of Msh2. Immunity 2003, 19:515-524.
118. Minegishi Y., Lavoie A., Cunningham-Rundles C., Bedard P.M., Hebert J., Cote L., Dan K., Sedlak D., Buckley R.H., Fischer A., Durandy A., Conley M.E. Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome. Clin. Immunol 2000, 97:203-210.
119. Morey N.J., Greene C.N., Jinks-Robertson S. Genetic analysis of transcription-associated mutation in Saccharomyces cerevisiae. Genetics 2000, 154:109-120.
120. Morisawa T., Marusawa H., Ueda Y., Iwai A., Okazaki I.M., Honjo T., Chiba T. Organ-specific profiles of genetic changes in cancers caused by activation-induced cytidine deaminase expression. Int. J. Cancer 2008, 123:2735-2740.
121. Mottok A., Hansmann M.L., Brauninger A. Activation induced cytidine deaminase expression in lymphocyte predominant Hodgkin lymphoma. J. Clin. Pathol. 2005, 58:1002-1004.
122. Muramatsu M., Sankaranand V.S., Anant S., Sugai M., Kinoshita K., Davidson N.O., Honjo T. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J. Biol. Chem. 1999, 274:18470-18476.
123. Muramatsu M., Kinoshita K., Fagarasan S., Yamada S., Shinkai Y., Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 2000, 102:553-563.
124. Muramatsu M., Nagaoka H., Shinkura R., Begum N.A., Honjo T. Discovery of activation-induced cytidine deaminase, the engraver of antibody memory. Adv. Immunol. 2007, 94:1-36.
125. Muto T., Muramatsu M., Taniwaki M., Kinoshita K., Honjo T. Isolation, tissue distribution, and chromosomal localization of the human activation-induced cytidine deaminase (AID) gene. Genomics 2000, 68:85-88.
126. Myers S., Bowden R., Tumian A., Bontrop R.E., Freeman C., MacFie T.S., McVean G., Donnelly P. Drive against hotspot motifs in primates implicates the PRDM9 gene in meiotic recombination. Science 2010, 327:876-879.
127. Nakamura M., Kondo S., Sugai M., Nazarea M., Imamura S., Honjo T. High frequency class switching of an IgM+ B lymphoma clone CH12F3 to IgA+ cells. Int. Immunol. 1996, 8:193-201.
128. Nakamura M., Sugita K., Sawada Y., Yoshiki R., Hino R., Tokura Y. High levels of activation-induced cytidine deaminase expression in adult T-cell leukaemia/lymphoma. Br. J. Dermatol. 2011, 165:437-439.
129. Nambu Y., Sugai M., Gonda H., Lee C.G., Katakai T., Agata Y., Yokota Y., Shimizu A. Transcription-coupled events associating with immunoglobulin switch region chromatin. Science 2003, 302:2137-2140.
130. Neuberger M.S., Harris R.S., Di Noia J., Petersen-Mahrt S.K. Immunity through DNA deamination. Trends Biochem. Sci. 2003, 28:305-312.
131. Nikaido T., Nakai S., Honjo T. Switch region of immunoglobulin Cmu gene is composed of simple tandem repetitive sequences. Nature 1981, 292:845-848.
132. Nonaka T., Doi T., Toyoshima T., Muramatsu M., Honjo T., Kinoshita K. Carboxy-terminal domain of AID required for its mRNA complex formation in vivo. Proc. Natl. Acad. Sci. USA 2009, 106:2747-2751.
133. Nowak U., Matthews A.J., Zheng S., Chaudhuri J. The splicing regulator PTBP2 interacts with the cytidine deaminase AID and promotes binding of AID to switch-region DNA. Nat. Immunol. 2011, 12:160-166.
134. Okazaki I.M., Kinoshita K., Muramatsu M., Yoshikawa K., Honjo T. The AID enzyme induces class switch recombination in fibroblasts. Nature 2002, 416:340-345.
135. Okazaki I.M., Hiai H., Kakazu N., Yamada S., Muramatsu M., Kinoshita K., Honjo T. Constitutive expression of AID leads to tumorigenesis. J. Exp. Med. 2003, 197:1173-1181.
136. Okazaki I.M., Okawa K., Kobayashi M., Yoshikawa K., Kawamoto S., Nagaoka H., Shinkura R., Kitawaki Y., Taniguchi H., Natsume T., Iemura S., Honjo T. Histone chaperone Spt6 is required for class switch recombination but not somatic hypermutation. Proc. Natl. Acad. Sci. USA 2011, 108:7920-7925.
137. Oppezzo P., Vuillier F., Vasconcelos Y., Dumas G., Magnac C., Payelle-Brogard B., Pritsch O., Dighiero G. Chronic lymphocytic leukemia B cells expressing AID display dissociation between class switch recombination and somatic hypermutation. Blood 2003, 101:4029-4032.
138. Palacios F., Moreno P., Morande P., Abreu C., Correa A., Porro V., Landoni A.I., Gabus R., Giordano M., Dighiero G., Pritsch O., Oppezzo P. High expression of AID and active class switch recombination might account for a more aggressive disease in unmutated CLL patients: link with an activated microenvironment in CLL disease. Blood 2010, 115:4488-4496.
139. Park S.R., Zan H., Pal Z., Zhang J., Al-Qahtani A., Pone E.J., Xu Z., Mai T., Casali P. HoxC4 binds to the promoter of the cytidine deaminase AID gene to induce AID expression, class-switch DNA recombination and somatic hypermutation. Nat. Immunol. 2009, 10:540-550.
140. Parvanov E.D., Petkov P.M., Paigen K. Prdm9 controls activation of mammalian recombination hotspots. Science 2010, 327:835.
141. Pasqualucci L., Neumeister P., Goossens T., Nanjangud G., Chaganti R.S., Kuppers R., Dalla-Favera R. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 2001, 412:341-346.
142. Pasqualucci L., Guglielmino R., Houldsworth J., Mohr J., Aoufouchi S., Polakiewicz R., Chaganti R.S., Dalla-Favera R. Expression of the AID protein in normal and neoplastic B cells. Blood 2004, 104:3318-3325.
143. Pasqualucci L., Kitaura Y., Gu H., Dalla-Favera R. PKA-mediated phosphorylation regulates the function of activation-induced deaminase (AID) in B cells. Proc. Natl. Acad. Sci. USA 2006, 103:395-400.
144. Pauklin S., Sernandez I.V., Bachmann G., Ramiro A.R., Petersen-Mahrt S.K. Estrogen directly activates AID transcription and function. J. Exp. Med. 2009, 206:99-111.
145. Pavri R., Gazumyan A., Jankovic M., Di Virgilio M., Klein I., Ansarah-Sobrinho C., Resch W., Yamane A., Reina San-Martin B., Barreto V., Nieland T.J., Root D.E., et al. Activation-induced cytidine deaminase targets DNA at sites of RNA polymerase II stalling by interaction with Spt5. Cell 2010, 143:122-133.
146. Peters A., Storb U. Somatic hypermutation of immunoglobulin genes is linked to transcription initiation. Immunity 1996, 4:57-65.
147. Petersen-Mahrt S.K., Neuberger M.S. In vitro deamination of cytosine to uracil in single-stranded DNA by apolipoprotein B editing complex catalytic subunit 1 (APOBEC1). J. Biol. Chem. 2003, 278:19583-19586.
148. Petersen-Mahrt S.K., Harris R.S., Neuberger M.S. AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature 2002, 418:99-103.
149. Poltoratsky V.P., Wilson S.H., Kunkel T.A., Pavlov Y.I. Recombinogenic phenotype of human activation-induced cytosine deaminase. J. Immunol. 2004, 172:4308-4313.
150. Qin H., Suzuki K., Nakata M., Chikuma S., Izumi N., Thi Huong L., Maruya M., Fagarasan S., Busslinger M., Honjo T., Nagaoka H. Activation-Induced Cytidine Deaminase Expression in CD4 T Cells is Associated with a Unique IL-10-Producing Subset that Increases with Age. PLoS One. 2011, 6:e29141.
151. Quartier P., Bustamante J., Sanal O., Plebani A., Debre M., Deville A., Litzman J., Levy J., Fermand J.P., Lane P., Horneff G., Aksu G., et al. Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to activation-induced cytidine deaminase deficiency. Clin. Immunol. 2004, 110:22-29.
152. Rabbitts T.H., Forster A., Dunnick W., Bentley D.L. The role of gene deletion in the immunoglobulin heavy chain switch. Nature 1980, 283:351-356.
153. Rada C., Ehrenstein M.R., Neuberger M.S., Milstein C. Hot spot focusing of somatic hypermutation in MSH2-deficient mice suggests two stages of mutational targeting. Immunity 1998, 9:135-141.
154. Rada C., Williams G.T., Nilsen H., Barnes D.E., Lindahl T., Neuberger M.S. Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice. Curr. Biol. 2002, 12:1748-1755.
155. Rada C., Di Noia J.M., Neuberger M.S. Mismatch recognition and uracil excision provide complementary paths to both Ig switching and the A/T-focused phase of somatic mutation. Mol. Cell 2004, 16:163-171.
156. Rajaram V., Knezevich S., Bove K.E., Perry A., Pfeifer J.D. DNA sequence of the translocation breakpoints in undifferentiated embryonal sarcoma arising in mesenchymal hamartoma of the liver harboring the t(11;19)(q11;q13.4) translocation. Genes Chromosomes Cancer 2007, 46:508-513.
157. Rajewsky K. Clonal selection and learning in the antibody system. Nature 1996, 381:751-758.
158. Ramiro A.R., Jankovic M., Eisenreich T., Difilippantonio S., Chen-Kiang S., Muramatsu M., Honjo T., Nussenzweig A., Nussenzweig M.C. AID is required for c-myc/IgH chromosome translocations in vivo. Cell 2004, 118:431-438.
159. Ranjit S., Khair L., Linehan E.K., Ucher A.J., Chakrabarti M., Schrader C.E., Stavnezer J. AID binds cooperatively with UNG and Msh2-Msh6 to Ig switch regions dependent upon the AID C terminus. J. Immunol. 2011, 187:2464-2475.
160. Reiniger L., Bodor C., Bognar A., Balogh Z., Csomor J., Szepesi A., Kopper L., Matolcsy A. Richter's and prolymphocytic transformation of chronic lymphocytic leukemia are associated with high mRNA expression of activation-induced cytidine deaminase and aberrant somatic hypermutation. Leukemia 2006, 20:1089-1095.
161. Revy P., Muto T., Levy Y., Geissmann F., Plebani A., Sanal O., Catalan N., Forveille M., Dufourcq-Labelouse R., Gennery A., Tezcan I., Ersoy F., et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 2000, 102:565-575.
162. Rosenwald A., Alizadeh A.A., Widhopf G., Simon R., Davis R.E., Yu X., Yang L., Pickeral O.K., Rassenti L.Z., Powell J., Botstein D., Byrd J.C., et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J. Exp. Med. 2001, 194:1639-1647.
163. Rosenwald A., Wright G., Chan W.C., Connors J.M., Campo E., Fisher R.I., Gascoyne R.D., Muller-Hermelink H.K., Smeland E.B., Giltnane J.M., Hurt E.M., Zhao H., et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N. Engl. J. Med. 2002, 346:1937-1947.
164. Sabouri Z., Okazaki I.M., Shinkura R., Begum N., Nagaoka H., Tsuchimoto D., Nakabeppu Y., Honjo T. Apex2 is required for efficient somatic hypermutation but not for class switch recombination of immunoglobulin genes. Int. Immunol. 2009, 21:947-955.
165. Saribasak H., Saribasak N.N., Ipek F.M., Ellwart J.W., Arakawa H., Buerstedde J.M. Uracil DNA glycosylase disruption blocks Ig gene conversion and induces transition mutations. J. Immunol. 2006, 176:365-371.
166. Satou Y., Yasunaga J., Zhao T., Yoshida M., Miyazato P., Takai K., Shimizu K., Ohshima K., Green P.L., Ohkura N., Yamaguchi T., Ono M., et al. HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo. PLoS Pathog. 2011, 7:e1001274.
167. Schatz D.G. Antigen receptor genes and the evolution of a recombinase. Semin. Immunol. 2004, 16:245-256.
168. Schrader C.E., Vardo J., Stavnezer J. Role for mismatch repair proteins Msh2, Mlh1, and Pms2 in immunoglobulin class switching shown by sequence analysis of recombination junctions. J. Exp. Med. 2002, 195:367-373.
169. Schroeder H.W., Dighiero G. The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire. Immunol. Today 1994, 15:288-294.
170. Shen H.M., Peters A., Baron B., Zhu X., Storb U. Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science 1998, 280:1750-1752.
171. Shen H.M., Ratnam S., Storb U. Targeting of the activation-induced cytosine deaminase is strongly influenced by the sequence and structure of the targeted DNA. Mol. Cell. Biol. 2005, 25:10815-10821.
172. Shen H.M., Poirier M.G., Allen M.J., North J., Lal R., Widom J., Storb U. The activation-induced cytidine deaminase (AID) efficiently targets DNA in nucleosomes but only during transcription. J. Exp. Med. 2009, 206:1057-1071.
173. Shinkura R., Ito S., Begum N.A., Nagaoka H., Muramatsu M., Kinoshita K., Sakakibara Y., Hijikata H., Honjo T. Separate domains of AID are required for somatic hypermutation and class-switch recombination. Nat. Immunol. 2004, 5:707-712.
174. Shivarov V., Shinkura R., Honjo T. Dissociation of in vitro DNA deamination activity and physiological functions of AID mutants. Proc. Natl. Acad. Sci. USA 2008, 105:15866-15871.
175. Smit L.A., Bende R.J., Aten J., Guikema J.E., Aarts W.M., van Noesel C.J. Expression of activation-induced cytidine deaminase is confined to B-cell non-Hodgkin's lymphomas of germinal-center phenotype. Cancer Res. 2003, 63:3894-3898.
176. Stanlie A., Aida M., Muramatsu M., Honjo T., Begum N.A. Histone3 lysine4 trimethylation regulated by the facilitates chromatin transcription complex is critical for DNA cleavage in class switch recombination. Proc. Natl. Acad. Sci. USA 2010, 107:22190-22195.
177. Staszewski O., Baker R.E., Ucher A.J., Martier R., Stavnezer J., Guikema J.E. Activation-induced cytidine deaminase induces reproducible DNA breaks at many non-Ig Loci in activated B cells. Mol. Cell 2011, 41:232-242.
178. Suzuki K., Meek B., Doi Y., Muramatsu M., Chiba T., Honjo T., Fagarasan S. Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut. Proc. Natl. Acad. Sci. USA 2004, 101:1981-1986.
179. Ta V.T., Nagaoka H., Catalan N., Durandy A., Fischer A., Imai K., Nonoyama S., Tashiro J., Ikegawa M., Ito S., Kinoshita K., Muramatsu M., et al. AID mutant analyses indicate requirement for class-switch-specific cofactors. Nat. Immunol. 2003, 4:843-848.
180. Takahashi T., Burguiere-Slezak G., Van der Kemp P.A., Boiteux S. Topoisomerase 1 provokes the formation of short deletions in repeated sequences upon high transcription in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA 2011, 108:692-697.
181. Takizawa M., Tolarova H., Li Z., Dubois W., Lim S., Callen E., Franco S., Mosaico M., Feigenbaum L., Alt F.W., Nussenzweig A., Potter M., et al. AID expression levels determine the extent of cMyc oncogenic translocations and the incidence of B cell tumor development. J. Exp. Med. 2008, 205:1949-1957.
182. Teng G., Hakimpour P., Landgraf P., Rice A., Tuschl T., Casellas R., Papavasiliou F.N. MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. Immunity 2008, 28:621-629.
183. Tran T.H., Nakata M., Suzuki K., Begum N.A., Shinkura R., Fagarasan S., Honjo T., Nagaoka H. B cell-specific and stimulation-responsive enhancers derepress Aicda by overcoming the effects of silencers. Nat. Immunol. 2010, 11:148-154.
184. Tuduri S., Crabbe L., Conti C., Tourriere H., Holtgreve-Grez H., Jauch A., Pantesco V., De Vos J., Thomas A., Theillet C., Pommier Y., Tazi J., et al. Topoisomerase I suppresses genomic instability by preventing interference between replication and transcription. Nat. Cell Biol. 2009, 11:1315-1324.
185. Turner N.C., Dusheiko G., Jones A. Hepatitis C and B-cell lymphoma. Ann. Oncol. 2003, 14:1341-1345.
186. Wahls W.P., Davidson M.K. Discrete DNA sites regulate global distribution of meiotic recombination. Trends Genet. 2010, 26:202-208.
187. Wei M., Shinkura R., Doi Y., Maruya M., Fagarasan S., Honjo T. Mice carrying a knock-in mutation of Aicda resulting in a defect in somatic hypermutation have impaired gut homeostasis and compromised mucosal defense. Nat. Immunol. 2011, 12:264-270.
188. Weigert M.G., Cesari I.M., Yonkovich S.J., Cohn M. Variability in the lambda light chain sequences of mouse antibody. Nature 1970, 228:1045-1047.
189. Willemze R., Jaffe E.S., Burg G., Cerroni L., Berti E., Swerdlow S.H., Ralfkiaer E., Chimenti S., Diaz-Perez J.L., Duncan L.M., Grange F., Harris N.L., et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005, 105:3768-3785.
190. Wu X., Geraldes P., Platt J.L., Cascalho M. The double-edged sword of activation-induced cytidine deaminase. J. Immunol. 2005, 174:934-941.
191. Xanthoudakis S., Smeyne R.J., Wallace J.D., Curran T. The redox/DNA repair protein, Ref-1, is essential for early embryonic development in mice. Proc. Natl. Acad. Sci. USA 1996, 93:8919-8923.
192. Yadav A., Olaru A., Saltis M., Setren A., Cerny J., Livak F. Identification of a ubiquitously active promoter of the murine activation-induced cytidine deaminase (AICDA) gene. Mol. Immunol. 2006, 43:529-541.
193. Yamane A., Resch W., Kuo N., Kuchen S., Li Z., Sun H.W., Robbiani D.F., McBride K., Nussenzweig M.C., Casellas R. Deep-sequencing identification of the genomic targets of the cytidine deaminase AID and its cofactor RPA in B lymphocytes. Nat. Immunol. 2011, 12:62-69.
194. Yamazaki J., Mizukami T., Takizawa K., Kuramitsu M., Momose H., Masumi A., Ami Y., Hasegawa H., Hall W.W., Tsujimoto H., Hamaguchi I., Yamaguchi K. Identification of cancer stem cells in a Tax-transgenic (Tax-Tg) mouse model of adult T-cell leukemia/lymphoma. Blood 2009, 114:2709-2720.
195. Yang G., Obiakor H., Sinha R.K., Newman B.A., Hood B.L., Conrads T.P., Veenstra T.D., Mage R.G. Activation-induced deaminase cloning, localization, and protein extraction from young VH-mutant rabbit appendix. Proc. Natl. Acad. Sci. USA 2005, 102:17083-17088.
196. Yaoita Y., Honjo T. Deletion of immunoglobulin heavy chain genes from expressed allelic chromosome. Nature 1980, 286:850-853.
197. Yoshikawa K., Okazaki I.M., Eto T., Kinoshita K., Muramatsu M., Nagaoka H., Honjo T. AID enzyme-induced hypermutation in an actively transcribed gene in fibroblasts. Science 2002, 296:2033-2036.
198. Zan H., Komori A., Li Z., Cerutti A., Schaffer A., Flajnik M.F., Diaz M., Casali P. The translesion DNA polymerase zeta plays a major role in Ig and bcl-6 somatic hypermutation. Immunity 2001, 14:643-653.
199. Zeitlin S.G., Chapados B.R., Baker N.M., Tai C., Slupphaug G., Wang J.Y. Uracil DNA N-glycosylase promotes assembly of human centromere protein A. PLoS One 2011, 6:e17151.
200. Zhang M., Swanson P.C. V(D)J recombinase binding and cleavage of cryptic recombination signal sequences identified from lymphoid malignancies. J. Biol. Chem. 2008, 283:6717-6727.
201. Zhang J., Bottaro A., Li S., Stewart V., Alt F.W. A selective defect in IgG2b switching as a result of targeted mutation of the I gamma 2b promoter and exon. EMBO J. 1993, 12:3529-3537.